Please wait a minute...
ZJUS-B
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2013, Vol. 14 Issue (6): 451-459    DOI: 10.1631/jzus.B1200230
Articles     
Effect of siRNA-mediated knockdown of eIF3c gene on survival of colon cancer cells
Ning Song, Yan Wang, Xiao-dong Gu, Zong-you Chen, Liu-bin Shi
Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Eukaryotic initiation factor subunit c (eIF3c) has been identified as an oncogene that is over-expressed in tumor cells and, therefore, is a potential therapeutic target for gene-based cancer treatment. This study was focused on investigating the effect of small interfering RNA (siRNA)-mediated eIF3c gene knockdown on colon cancer cell survival. The eIF3c gene was observed to be highly expressed in colon cancer cell models. The expression levels of the gene in eIF3c siRNA infected and control siRNA infected cells were compared via real-time polymerase chain reaction (PCR) and western blotting analysis. Cell proliferation levels were analyzed employing 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and colony formation assays. Furthermore, the effects of eIF3c gene knockdown on the cell cycle and apoptosis were analyzed using flow cytometry. The results showed that suppression of eIF3c expression significantly (P<0.001) reduced cell proliferation and colony formation of RKO colon cancer cells. The cell cycle was arrested by decreasing the number of cells entering S phase. Further, apoptosis was induced as a result of eIF3c knockdown. Collectively, eIF3c deletion effectively reduced the survival of colon cancer cells and could be used as a therapeutic tool for colon cancer therapy.

Key words： Eukaryotic initiation factor subunit c (eIF3c)      Colon cancer      RKO cells      Small interfering RNA (siRNA)     
Received: 24 August 2012      Published: 04 June 2013
CLC:  R735.3+5  
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
Ning Song
Yan Wang
Xiao-dong Gu
Zong-you Chen
Liu-bin Shi
Cite this article:

Ning Song, Yan Wang, Xiao-dong Gu, Zong-you Chen, Liu-bin Shi. Effect of siRNA-mediated knockdown of eIF3c gene on survival of colon cancer cells. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2013, 14(6): 451-459.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.B1200230     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2013/V14/I6/451

[1] Jian-zhen Shan, Yan-yan Xuan, Qi Zhang, Jian-jin Huang. Ursolic acid sensitized colon cancer cells to chemotherapy under hypoxia by inhibiting MDR1 through HIF-1α[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(9): 672-682.
[2] Zhan-huai Wang, Qiong Li, Shu-qin Ruan, Qian Xiao, Yue Liu, Ye-ting Hu, Li-feng Hu, Hai-yan Chen, Shu Zheng, Su-zhan Zhang, Ke-feng Ding. Sunitinib mesylate inhibits proliferation of human colonic stromal fibroblasts in vitro and in vivo[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(8): 701-712.
[3] Zhan-huai Wang, Ke-feng Ding, Jie-kai Yu, Xiao-hui Zhai, Shu-qin Ruan, Shan-wei Wang, Yong-liang Zhu, Shu Zheng, Su-zhan Zhang. Proteomic analysis of primary colon cancer-associated fibroblasts using the SELDI-ProteinChip platform[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2012, 13(3): 159-167.
[4] Jian-zhen SHAN, Yan-yan XUAN, Shu ZHENG, Qi DONG, Su-zhan ZHANG. Ursolic acid inhibits proliferation and induces apoptosis of HT-29 colon cancer cells by inhibiting the EGFR/MAPK pathway[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2009, 10(9): 668-674.
[5] Shao-xing CHEN, Feng-ying HUANG, Guang-hong TAN, Cai-chun WANG, Yong-hao HUANG, Hua WANG, Song-lin ZHOU, Fan CHEN, Ying-ying LIN, Jun-bao LIU. RNA interference against interleukin-5 attenuates airway inflammation and hyperresponsiveness in an asthma model[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2009, 10(1): 22-28.